Markus Hosang
General Partner
BUSINESS MANAGEMENT
Aleva Neurotherapeutics
United States of America
Biography
Markus Hosang is a General Partner at BioMedPartners AG in Basel. He has strong experience and broad knowledge in strategic and operational aspects of the venture capital business, as well as in pharmaceutical and diagnostics research and in many product development and marketing areas. Before joining BioMedPartners in 2004, Dr. Hosang was a Venture Partner at MPM Capital, where he was co-responsible for their European investment activities. Previously, he was a Vice President at Roche in Basel, where he held several senior management positions in the Pharma R&D organization.. Dr. Hosang currently is a member of the boards of Aleva SA, Anergis SA, Okairos AG and Suppremol GmbH. Earlier he was on the boards of Omrix, Kourion, IDEA, Atugen, Avontec and Neuraxo
Research Interest
BUSINESS MANAGEMENT
